Laddar populära aktier...
GÖTEBORG, 9 december 2024
Carasent ASA - Mandatory notifications of trades resulting from merger of Carasent ASA into Carasent AB (publ)
Carasent ASA has completed its planned cross-border merger with Carasent AB.
The cross-border merger between Carasent ASA and Carasent AB is planned to be completed after close of trading on Oslo Børs on 4 December 20...
Carasent AB (publ) (”Carasent” eller ”Bolaget”) offentliggör idag prospekt i samband med Bolagets notering av dess aktier på Nasdaq Stockhol...
Carasent AB (publ) (“Carasent” or the “Company”) today publishes a prospectus in connection with the Company’s listing of its shares on Nasd...
Nasdaq Stockholm has today notified Carasent AB (publ) (“Carasent” or the “Company”) of its assessment that the Company fulfills Nasdaq Stoc...
Carasent ASA (“Carasent”) has today acquired the German company Data-Al GmbH (“Data-Al”), a provider of electronic health record (“EHR”) sol...
Please find attached Carasent ASA Q3 2024 report and presentation.
Carasent ASA will present its Q3 2024 financial results as a webcast on 24 October at 8:00.
Reference is made to Carasent AS´s (“Carasent” or the “Company”) stock exchange and press release 30 August 2024 regarding the merger plan f...
Reference is made to Carasent ASA’s (“Carasent” or the “Company”) stock exchange and press release 30 August 2024 regarding the merger plan ...
Carasent ASA - Calling notice for extraordinary general meeting
Carasent’s board of directors has resolved on a cross-border merger plan to effect the planned relisting of its shares on Nasdaq Stockholm
Please find attached Carasent ASA Q2 2024 report and presentation.
Carasent ASA will present its Q2 2024 Financial Results as a webcast on 12 July at 8:00.
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR...
Frelsesarmeen and Carasent Norway have entered into an agreement to implement the EHR system Ad Curis at Frelsesarmeen’s addiction care and ...
The offer is likely to be rejected by above 39% of shareholders unless price is significantly increased.
CARASENT COMMENTS ON EG’S INTENTION TO LAUNCH VOLUNTARY CASH OFFER
Carasent ASA - Q1 2024 presentation
Please find attached Carasent ASA Q1 2024 financial results and presentation.
Carasent ASA - announcement of revised financial targets
Carasent ASA will present its Q1 2024 Financial Results as a webcast on 24 April at 8:00 a.
Please find attached the Minutes with attachments from today's Annual General Meeting in Carasent ASA.
Västra Götalands Regionen and Medrave AB have today entered into an agreement to implement Medrave to the EHR system Millennium.
Carasent ASA has updated its financial calendar for 2024 with a new date for the half-yearly report.
Carasent ASA - Calling notice for annual general meeting
Carasent ASA - Completion of employee share purchase program
Carasent ASA - Annual Report 2023
Carasent ASA - Share capital reduction
Carasent ASA - Q4 2023 financial results and presentation
Carasent ASA will present its Q4 2023 Financial Results as a webcast on 15 February at 8:00 a.
Carasent has today entered into a contract to sell the Confrere brand and customer contracts to Compodium International AB ("Compodium").
Carasent ASA - Minutes from the Extraordinary General Meeting
Reference is made to the stock exchange release 29 December 2023 regarding the Extraordinary General Meeting on 22 January 2024.
Carasent ASA – Demand by ACapital Cara HoldCo AS for extraordinary general meeting
Board member Staffan Hanstorp has given notice of his resignation as a member of the board of directors of Carasent ASA with immediate effec...
Financial calendar for Carasent ASA
Volvat Medisinske Senter AS and Metodika AB have entered into an agreement to implement the EHR system Metodika EPM at Volvat’s hospitals an...
Carasent ASA - Ex dividend today
Please find attached the Minutes with attachments from today's Extraordinary General Meeting in Carasent ASA.
Carasent ASA - Capital Markets Day presentation
Carasent ASA (“Carasent”, or the “Company”) has today updated its financial targets for long-term revenue growth and profitability.
Carasent ASA - Q3 2023 financial results and presentation
Carasent ASA will present its Q3 2023 Financial Results as a webcast on 26 October at 8:00 a.
Reference is made to the notice issued on 21 October 2023, where the Board of Carasent ASA has proposed a cash distribution on ordinary shar...
Reference is made to the notice issued on 21 September 2023, where Carasent ASA announced an invitation to investors and other interested pa...
13,319,838 shares in Carasent ASA were Friday, 29 September 2023 resolved to be transferred from Aeternum Capital AS to ACapital CARA HoldCo...
Reference is made to the notice issued on 25 September 2023, where Carasent ASA (the "Company") launched an offer to all shareholders to pur...
Carasent ASA (“Carasent” or the “Company) refers to the stock exchange release 22 September 2023 in respect of the Distribution (as defined ...
